Under normal conditions, GFAP is not typically detected in the serum [59]; however, in patients who have experienced a brain injury such as stroke, levels often increase secondary to reactive astrogliosis—a process characterized by the proliferation and hypertrophy of astrocytes in response to damage. This evidence concerns the gene GFAP and stroke disorder.